08:47:08 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for Nov. 16, 2016

2016-11-16 20:50 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange lost 5.31 points to 741.85 Wednesday. Dave Doherty and Frank Taggart's halted capital pool shell, Saber Capital Corp. (SAB), has cancelled a $5.5-million offering of notes, but not for the typical reason of insufficient investor interest. Saber's reason is the opposite. The shell had intended to complete three financings: the above-mentioned $5.5-million note offering, a $2-million unit offering and a $16-million private placement (half brokered, half non-brokered) of subscription receipts at $1.15. It has now closed the private placement, raising $21.55-million from the sale of 18,744,396 subscription receipts. Having exceeded its private placement target by $5.55-million, it no longer needs to sell notes, but it still plans to complete its $2-million unit offering. It has not yet set the terms for this.

Saber Capital's qualifying transaction target is Emblem Corp. (also known as Emblem Cannabis Corp. and previously Emblem Holdings Ltd.), a licensed medical marijuana grower and seller with a facility in Paris, Ont. Pot promotions are attracting a lot of attention these days, and this day most of the attention was watching them fall, with one exception. Five of them were particularly overactive traders, triggering the exchange's single-stock circuit breaker for a combined 13 times: Aurora Cannabis Inc. (ACB), the exception, which rose 31 cents to $2.94 on 41.81 million shares; Canopy Growth Corp. (CGC), which fell $2.05 to $11.40 on 33.06 million shares; Aphria Inc. (APH), down 53 cents to $5.77 on 20.79 million shares; Organigram Holdings Inc. (OGI), down 42 cents to $3.42 on 18.56 million shares; and Mettrum Health Corp. (MT), down 80 cents to $6 on 8.16 million shares. All five went public through shells in 2014.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed